|
ISMRM 23rd Annual Meeting & Exhibition • 30 May - 05 June 2015 • Toronto, Ontario, Canada |
||||||||||
|
||||||||||
| Overview The clinical importance of using MR techniques for monitoring tumor response to anticancer therapy is rapidly growing. Recent advances in the design of therapeutic agents and methods have made it possible to combine cancer therapy with MR imaging as well as other imaging modalities to enable theranostic MRI. The goal of this educational session is to inform about the use MRI techniques for therapeutic monitoring and theranostics in evaluating the response of a given cancer to a therapy of choice. Target Audience Clinicians and M.D. & Ph.D. researchers who will benefit from tools and techniques for noninvasive measuring tumor response to therapy and combining therapy with MR imaging for theranostic MRI. Educational Objectives As a result of attending this course, participants should be able to: • Assess the advantages and disadvantages of different MR techniques for measuring tumor response to therapy; • Evaluate the added value of different MR approaches to monitor early and/or late events in a tumor's metabolism, physiology, or cellularity as a response to a given anticancer therapy; and • Integrate different concepts of theranostic MRI to develop a suitable approach for a given cancer and therapy of choice. |
||||||||||
| PROGRAM | ||||||||||
| Moderators: Kristine Glunde, Ph.D., Guanshu Liu, Ph.D. | ||||||||||
|
||||||||||
